A review on the cultivation, bioactive compounds, health-promoting factors and clinical trials of medicinal mushrooms Taiwanofungus camphoratus, Inonotus obliquus and Tropicoporus linteus
Tee PYE, Krishnan T, Cheong XT, Maniam SAP, Looi CY
Published in Fungal Biology and Biotechnology
Methodology
Review of cultivation, phytochemistry, pharmacology and registered clinical trials for three medicinal mushrooms including I. obliquus
Key Findings
Anticancer, hypoglycaemic, hypolipidaemic, antioxidant and antiviral properties are documented, but registered human trials for I. obliquus remain scarce.
Conclusions
Health claims currently rest on preclinical pharmacology rather than completed clinical trials.
Limitations
Review pools three different species; limited critical appraisal of individual study quality.
Supplements Studied
Evidence of the robust pharmacological properties, including their anticancer, hypoglycemic, hypolipidemic, antioxidant, and antiviral activities, have been provided in various studies.
Outcomes Measured
Evidence of the robust pharmacological properties, including their anticancer, hypoglycemic, hypolipidemic, antioxidant, and antiviral activities, have been provided in various studies.
Study Details
Access Study
Disclosures
Funding
Not reported
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.